Back to Search Start Over

A randomised controlled trial of integrated psychological therapy for traumatic stress and substance use among adolescents: Trial protocol

Authors :
Mills, Katherine
Barrett, Emma
Back, Sudie
Cobham, Vanessa
Bendall, Sarah
Perrin, Sean
Brady, Kathleen
Ross, Joanne
Peach, Natalie
Kihas, Ivana
Cassar, Joanne
Schollar-Root, Olivia
Teesson, Maree
Source :
BMJ Open; 10, no e043742 (2020)
Publication Year :
2020
Publisher :
BMJ Publishing Group, 2020.

Abstract

Introduction: Post-traumatic stress disorder (PTSD) and substance use disorder frequently co-occur and tend to have their onset during adolescence. Although research has highlighted the importance of treating these disorders in an integrated fashion, there is a dearth of empirically validated integrated treatment options for adolescents with this comorbidity. This paper describes the study protocol for a randomised controlled trial (RCT) examining the efficacy of an integrated trauma-focused cognitive–behavioural treatment for traumatic stress and substance use among adolescents (Concurrent Treatment of PTSD and Substance Use Using Prolonged Exposure - Adolescent (COPE-A)), relative to a supportive counselling control condition (Person-Centred Therapy (PCT)). Methods and analysis: A two-arm, parallel, single-blind RCT with blinded follow-up at 4 and 12 months poststudy entry will be conducted in Sydney, Australia. Participants (n~100 adolescents aged 12–18 years) and their caregivers (caregiver participation is optional) will be allocated to undergo either COPE-A or PCT (allocation ratio 1:1) using minimisation. Both therapies will be delivered individually by project psychologists over a maximum of 16 sessions of 60–90 min duration and will include provision of up to four 30 min optional caregiver sessions. The primary outcome will be between-group differences in change in the severity of PTSD symptoms from baseline to 4-month follow-up, as measured by the Clinician-Administered PTSD Scale for Children and Adolescents for DSM-5. Ethics and dissemination: Ethical approval has been obtained from the human research ethics committees of the Sydney Children’s Hospital Network (HREC/17/SCHN/306) and the University of Sydney (HREC 2018/863). Findings will be published in peer-reviewed journals and presented at scientific conferences. Trial registration number: ACTRN12618000785202; Pre-reults.

Details

Language :
English
ISSN :
20446055
Database :
OpenAIRE
Journal :
BMJ Open; 10, no e043742 (2020)
Accession number :
edsair.od......1110..afafb731695c94e8db60ab69f332835c